
Uprise Healthcare Llp
Founded in 2015 and headquartered in Maharashtra, India.
Founded in 2015 and headquartered in Maharashtra, India.
Uprise Healthcare Llp (UHL) is 9 Year, 4 Months old Limited Liability Partnership 12 October 2015. Its registered office is in Mumbai, Maharashtra, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
-
AAE-9065
12 Oct 2015
31 Mar 2023
Roc-Mumbai
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Naresh Mehta ![]() | Designated Partner | 17-May-2018 | Current |
Harsh Mehta ![]() | Designated Partner | 12-Oct-2015 | Current |
Enhance accessibility to Uprise Healthcare Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Uprise Healthcare Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Naresh Mehta is a mutual person
Naresh Mehta is a mutual person
Harsh Mehta is a mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Uprise Healthcare Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uprise Healthcare Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uprise Healthcare Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Uprise Healthcare Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Mumbai.
Naresh Jayantilal Mehta was appointed as a Designated Partner was appointed as a Designated Partner on 17 May 2018 & has been associated with this company since 6 years 9 months .
Harsh Naresh Mehta was appointed as a Designated Partner was appointed as a Designated Partner on 12 Oct 2015 & has been associated with this company since 9 years 4 months .
Uprise Healthcare Llp was registered on 12 Oct 2015 with RoC-Mumbai & aged 9 years 4 months as per MCA records.
Uprise Healthcare Llp was incorporated on 12 Oct 2015.
The Obligation of Contribution of Uprise Healthcare Llp is ₹ 0.10 M.
Currently 2 partners are associated with Uprise Healthcare Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Uprise Healthcare Llp is 106 Sra Building Plot No-37 Phirozshah Mehta Road, Santacruz - West Na City, Mumbai, Maharashtra, India, 400054.
The Limited Liability Partnership Identification Number (LLPIN) of Uprise Healthcare Llp is AAE-9065.
The most recent Balance Sheet for Uprise Healthcare Llp was filed with the ROC on 31 Mar 2023.